This site is intended for U.S. healthcare professionals.
Menu
Close
Menu
Close
XYNTHA SOLOFUSE can help your patients live actively.
XYNTHA is indicated for bleed treatment, control, and protection in adults and children with hemophilia A
Across clinical trials of previously treated patients (PTPs), XYNTHA has demonstrated a low rate of inhibitor formation
XYNTHA SOLOFUSE comes in a travel-ready kit and keeps your patients ready to infuse on the go
To report an adverse event, please call 1-800-438-1985
Pfizer for Professionals 1-800-505-4426
This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.
© 2024 Pfizer Inc. All rights reserved.
Please see full Prescribing Information for XYNTHA and XYNTHA SOLOFUSE.
XYNTHA® Antihemophilic Factor (Recombinant) is indicated in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, for perioperative management, and for routine prophylaxis to reduce the frequency of bleeding episodes.
XYNTHA is not indicated in patients with von Willebrand’s disease.
Please see full Prescribing Information for XYNTHA and XYNTHA SOLOFUSE.